Here are the S-3 shelf registrations from Vanda Pharmaceuticals Inc. (VNDA) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow VNDA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VNDA filings page.
Vanda Pharmaceuticals Inc. has filed a shelf registration to offer up to $200,000,000 of securities. The company may, from time to time, sell common stock, preferred stock, debt securities, warrants or units in one or more offerings, with terms set in future supplements.
The securities may be sold directly, through agents, or via underwriters, and net proceeds are intended for general corporate purposes. Vanda’s common stock trades on the Nasdaq Global Market under the symbol VNDA, with a last reported sale price of $7.43 per share on February 11, 2026.